Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

Collaboration › Details

Editas Medicine–Chardan: investor conference, 201910 supply service Editas participates in Chardan Genetic Medicines Conference in New York

	Period	2019-10-07 ï¿½ 2019-10-08
	Region	New York, NY
	Country	United States (USA)
	Partner, 1st	Editas Medicine Inc. (Nasdaq: EDIT)
	Partner, 2nd	Chardan Capital Markets LLC
	Product	Chardan Genetic Medicines Conference 2019 New York
	Product 2	CRISPR gene editing technology
	Source	Editas Medicine, Inc.. (8/6/19). "Press Release: Editas Medicine Announces Second Quarter 2019 Results and Update". Cambridge, MA.

Record changed: 2019-09-02

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px

More documents for Editas Medicine Inc. (Nasdaq: EDIT)

[1] Editas Medicine, Inc.. (11/12/19). "Press Release: Editas Medicine and Celgene Corporation Amend Existing Collaboration to Develop and Commercialize Autologous and Allogeneic T Cell Medicines for the Treatment of Cancer and Autoimmune Diseases". Cambridg...
[2] Editas Medicine, Inc.. (11/12/19). "Press Release: Editas Medicine Announces Third Quarter 2019 Results and Update". Cambridge, MA....
[3] Editas Medicine, Inc.. (10/28/19). "Press Release: Editas Medicine Appoints Judith R. Abrams, M.D., as Chief Medical Officer". Cambridge, MA....
[4] Editas Medicine, Inc.. (10/15/19). "Press Release: Editas Medicine and AskBio Enter Strategic Research Collaboration to Explore In Vivo Delivery of Genome Editing Medicines to Treat Neurological Diseases". Cambridge, MA & Research Triangle Park, NC....
[5] Editas Medicine, Inc.. (8/6/19). "Press Release: Editas Medicine Announces Second Quarter 2019 Results and Update". Cambridge, MA....
[6] Editas Medicine, Inc.. (8/6/19). "Press Release: Editas Medicine Appoints Cynthia Collins as President and Chief Executive Officer". Cambridge, MA....
[7] Editas Medicine, Inc.. (4/3/19). "Press Release: Editas Medicine and BlueRock Therapeutics Enter Strategic Research Collaboration and Cross-Licensing Agreement to Combine Genome Editing and Cell Therapy Platforms". Cambridge, MA....
[8] Editas Medicine, Inc.. (1/22/19). "Press Release: Editas Medicine Announces Chief Executive Officer Transition. Katrine Bosley to Step Down as President and CEO". Cambridge, MA....
[9] Editas Medicine, Inc.. (1/21/19). "Press Release: Editas Medicine Announces Publication in Nature Medicine of Data Supporting the Development of EDIT-101 to Treat Leber Congenital Amaurosis 10 (LCA10)". Cambridge, MA....
[10] Editas Medicine, Inc.. (1/7/19). "Press Release: Editas Medicine Reports on Recent Progress at J.P. Morgan Healthcare Conference". Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]